Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Review · October 18, 2022

Systemic Combined Therapy With Anti-VEGF/TKI and Immunotherapy for HCC Downstaging in Liver Transplantation

Hepatology (Baltimore, Md.)


Additional Info

Hepatology (Baltimore, Md.)
Hepatocellular carcinoma downstaging for liver transplantation in the era of systemic combined therapy with anti-VEGF/TKI and immunotherapy
Hepatology 2022 Oct 01;76(4)1203-1218, NH Tran, S Muñoz, S Thompson, CL Hallemeier, J Bruix

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading